NCT04672278

Lipid-Lowering Effect and Hypotensive Effect of Shanzha Fruit Drink in Patients

A Randomized, Double-Blind, Placebo-Controlled Cross-Over Study to Evaluate the Safety, Lipid-Lowering Effect and Hypotensive Effect of Shanzha Fruit Drink in Patients With Mild to Moderate Hyperlipidemia

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 72 (actual)
• Sponsor: Chinese University of Hong Kong · Academic / Other
• Sex: All
• Age: 18 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

This is a single-center, randomized, double-blind, placebo-controlled, cross-over study. Subjects who meet the inclusion/exclusion criteria will be randomly and alternatively assigned to receive Shanzha fruit drink or placebo drink in the first 2 months or the last two months of the 5 months study period. In between the first and second treatment period, all patients will enter a Washout Period of 4 weeks and during which time patients should not receive any of the study functional fruit drink.

Conditions

• Hyperlipidemia
• Hypertension

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Shanzha Fruit drink or placebo drink	The dosage of Shanzha fruit drink or the placebo is 3 cans per day

Timeline

• Start date: 2019-01-02
• Primary completion: 2020-10-30
• Completion: 2020-10-30
• First posted: 2020-12-17
• Last updated: 2021-04-23

Locations

1 site across 1 country: Hong Kong